It's a triple-digit day for the Dow, with the benchmark index up more than 130 points in recent market action. That's a bit of a comedown from earlier when the Dow Jones Industrial Average had climbed more than 160 points, pushed higher by a strong earnings report from J.P. Morgan (JPM).
Up 0.7%, the Dow was trading recently at 18,503.82, while the S&P 500 climbed 0.5% to reach 2,163.05. The Nasdaq gained 0.54% to trade at 2,163.06.
Investors shrugged off a surprise decision by the Bank of England to stand pat on interest rates. Meanwhile, J.P. Morgan’s earnings report pulled shares of other mega banks higher, and energy stocks climbed along with oil prices.
The Financial Select Sector SPDR ETF (XLF) rose 1% to a recent $23.58, while the Energy Select Sector SPDR ETF (XLE) gained 0.43% to trade at $69.22.
U.S. stock indices have hit new record highs for the past three sessions, and seem on track to go for a fourth.
"Investors have fully accepted the idea that stocks yielding something are better than government bonds yielding almost nothing (or negative) and corporate bonds yielding very little," says Dennis DeBusschere at Evercore ISI.
Top Energy Stocks To Invest In Right Now: Exelixis, Inc.(EXEL)
Advisors' Opinion:- [By Ethan Ryder]
Exelixis (NASDAQ:EXEL) – Investment analysts at William Blair raised their FY2018 earnings per share (EPS) estimates for shares of Exelixis in a research report issued to clients and investors on Thursday, May 3rd. William Blair analyst A. Hsieh now anticipates that the biotechnology company will post earnings per share of $0.90 for the year, up from their previous estimate of $0.66. William Blair currently has a “Buy” rating on the stock. William Blair also issued estimates for Exelixis’ Q1 2019 earnings at $0.23 EPS, Q2 2019 earnings at $0.25 EPS, Q3 2019 earnings at $0.27 EPS and Q4 2019 earnings at $0.29 EPS.
- [By Joseph Griffin]
Exelixis (NASDAQ:EXEL) – Equities researchers at Oppenheimer raised their Q2 2018 earnings per share (EPS) estimates for Exelixis in a report issued on Wednesday, May 2nd. Oppenheimer analyst L. Cann now forecasts that the biotechnology company will post earnings of $0.11 per share for the quarter, up from their prior forecast of $0.09. Oppenheimer currently has a “Outperform” rating and a $40.00 target price on the stock. Oppenheimer also issued estimates for Exelixis’ Q3 2018 earnings at $0.13 EPS, Q4 2018 earnings at $0.14 EPS and FY2018 earnings at $0.74 EPS.
- [By Cory Renauer]
Exelixis, Inc. (NASDAQ:EXEL) investors have learned the hard way that highly successful drug launches can be awfully tricky. Shares of this cancer drug developer rocketed 439% higher during the two years leading up to 2018, but investors are worried that a combination treatment from Bristol-Myers Squibb (NYSE:BMY) will make life very difficult for the smaller company's U.S. sales force.
- [By Brian Feroldi, Keith Speights, and Sean Williams]
With that in mind, we asked a team of Motley Fool investors to highlight a biotech stock that they think is a strong buy right now. Here's why they picked Exelixis (NASDAQ:EXEL), Celgene (NASDAQ:CELG), and Ionis Pharmaceuticals (NASDAQ:IONS).
- [By ]
Cramer was bearish on Xilinx (XLNX) , Celgene (CELG) , Exelixis (EXEL) , Moneygram (MGI) , Monster Beverage (MNST) , SunCoke Energy Partners (SXCP) and Mattel (MAT) .
Top Energy Stocks To Invest In Right Now: Seadrill Limited(SDRL)
Advisors' Opinion:- [By Lisa Levin]
Thursday afternoon, the energy shares rose 1.16 percent. Meanwhile, top gainers in the sector included Seadrill Limited (NYSE: SDRL), up 33 percent, and Ultra Petroleum Corp. (NYSE: UPL) up 14 percent.
- [By Lisa Levin]
Wednesday afternoon, the energy shares climbed 1.59 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 77 percent, and EP Energy Corporation (NYSE: EPE), up 19 percent.
- [By Asit Sharma]
Last year, net income dropped from $146.4 million to $101.2 million, creating the sharp trend line seen above. The 2017 earnings dip can be traced to numerous factors, including higher interest expense, a reduction in tanker income, fewer ships in the fleet on charter to former parent Frontline Shipping (NYSE:FRO), and the bankruptcy filing of Seadrill Ltd. (NYSE:SDRL). Seadrill's reorganization has impacted Ship Finance's offshore revenue, as it has three out of four offshore drilling rigs on charter to affiliates of Seadrill.
- [By Lisa Levin]
Wednesday morning, the energy shares climbed 1.29 percent. Meanwhile, top gainers in the sector included SeaDrill Limited (NYSE: SDRL), up 19 percent, and Energy XXI Gulf Coast, Inc. (NASDAQ: EGC), up 10 percent.
- [By Jason Hall and Tyler Crowe]
In this week's episode of Industry Focus: Energy, host Nick Sciple, together with Jason Hall and Tyler Crowe, explain how offshore companies work, where the industry is today, and what investors should watch with these companies. Tune in to learn what sets Transocean (NYSE:RIG), Diamond Offshore (NYSE:DO), Seadrill (NYSE:SDRL), and Ensco (NYSE:ESV) apart from each other, what kind of risk/reward profile each company has to offer, some critical points and trends investors need to know before diving into offshore, and much more.
- [By John Bromels]
Unless it's not. Which it may not be. There's a big cloud of uncertainty hanging over the company, in part thanks to its status as a very small fish in a very big deepwater ocean that's full of huge, hungry competitors like Transocean (NYSE:RIG) and Ensco (NYSE:ESV). Questions also abound about its parent company, Seadrill (NYSE:SDRL).
Top Energy Stocks To Invest In Right Now: Haverty Furniture Companies, Inc.(HVT)
Advisors' Opinion:- [By Ethan Ryder]
Havertys (NYSE:HVT) – Stock analysts at KeyCorp dropped their Q2 2018 earnings per share estimates for Havertys in a research report issued on Wednesday, May 2nd. KeyCorp analyst B. Thomas now anticipates that the company will post earnings per share of $0.29 for the quarter, down from their previous forecast of $0.31. KeyCorp also issued estimates for Havertys’ Q3 2018 earnings at $0.39 EPS and Q4 2018 earnings at $0.45 EPS.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Havertys (HVT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Havertys (HVT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment